Cargando…
P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429187/ http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8 |
_version_ | 1785090647965827072 |
---|---|
author | Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie Wang, Jin MI, Jian‑qing |
author_facet | Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie Wang, Jin MI, Jian‑qing |
author_sort | Liu, Weiyang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104291872023-08-17 P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie Wang, Jin MI, Jian‑qing Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429187/ http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie Wang, Jin MI, Jian‑qing P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title | P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title_full | P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title_fullStr | P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title_full_unstemmed | P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title_short | P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE |
title_sort | p370: efficacy and safety of the third-generation tki olverembatinib in adults ph/bcr-abl1-positive acute lymphoblastic leukemia with t315i mutation and relapsed/refractory disease |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429187/ http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8 |
work_keys_str_mv | AT liuweiyang p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT liuyuanfang p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT zhuyongmei p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT wengxiangqin p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT wangcheng p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT ouyangwanyan p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT xujie p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT wangjin p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease AT mijianqing p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease |